These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32533104)

  • 1. Lentiviral gene therapy rescues p47
    Schejtman A; Aragão-Filho WC; Clare S; Zinicola M; Weisser M; Burns SO; Booth C; Gaspar HB; Thomas DC; Condino-Neto A; Thrasher AJ; Santilli G
    Gene Ther; 2020 Sep; 27(9):459-469. PubMed ID: 32533104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47
    Schejtman A; Vetharoy W; Choi U; Rivat C; Theobald N; Piras G; Leon-Rico D; Buckland K; Armenteros-Monterroso E; Benedetti S; Ashworth MT; Rothe M; Schambach A; Gaspar HB; Kang EM; Malech HL; Thrasher AJ; Santilli G
    Hum Gene Ther; 2021 Sep; 32(17-18):949-958. PubMed ID: 33740872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-generated p47
    Wrona D; Siler U; Reichenbach J
    Sci Rep; 2017 Mar; 7():44187. PubMed ID: 28287132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted knock-in of
    Siow KM; Güngör M; Wrona D; Raimondi F; Pastukhov O; Tsapogas P; Menzi T; Schmitz M; Kulcsár PI; Schwank G; Schulz A; Jinek M; Modlich U; Siler U; Reichenbach J
    Mol Ther Nucleic Acids; 2024 Sep; 35(3):102229. PubMed ID: 38952440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Granulomatous Disease: a Comprehensive Review.
    Yu HH; Yang YH; Chiang BL
    Clin Rev Allergy Immunol; 2021 Oct; 61(2):101-113. PubMed ID: 32524254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.
    Chiriaco M; Salfa I; Di Matteo G; Rossi P; Finocchi A
    Pediatr Allergy Immunol; 2016 May; 27(3):242-53. PubMed ID: 26680691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.
    Santilli G; Almarza E; Brendel C; Choi U; Beilin C; Blundell MP; Haria S; Parsley KL; Kinnon C; Malech HL; Bueren JA; Grez M; Thrasher AJ
    Mol Ther; 2011 Jan; 19(1):122-32. PubMed ID: 20978475
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Kuhns DB; Hsu AP; Sun D; Lau K; Fink D; Griffith P; Huang DW; Priel DAL; Mendez L; Kreuzburg S; Zerbe CS; De Ravin SS; Malech HL; Holland SM; Wu X; Gallin JI
    Blood Adv; 2019 Jan; 3(2):136-147. PubMed ID: 30651282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
    Brendel C; Rothe M; Santilli G; Charrier S; Stein S; Kunkel H; Abriss D; Müller-Kuller U; Gaspar B; Modlich U; Galy A; Schambach A; Thrasher AJ; Grez M
    Hum Gene Ther Clin Dev; 2018 Jun; 29(2):69-79. PubMed ID: 29664709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of patients with p47-phox-deficient chronic granulomatous disease: The significance of recombination events between the p47-phox gene (NCF1) and its highly homologous pseudogenes.
    Vázquez N; Lehrnbecher T; Chen R; Christensen BL; Gallin JI; Malech H; Holland S; Zhu S; Chanock SJ
    Exp Hematol; 2001 Feb; 29(2):234-43. PubMed ID: 11166463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy.
    Brendel C; Hänseler W; Wohlgensinger V; Bianchi M; Tokmak S; Chen-Wichmann L; Kuzmenko E; Cesarovic N; Nicholls F; Reichenbach J; Seger R; Grez M; Siler U
    Hum Gene Ther Methods; 2013 Jun; 24(3):151-9. PubMed ID: 23489116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
    Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
    Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort.
    Baris HE; Ogulur I; Akcam B; Kiykim A; Karagoz D; Saraymen B; Akgun G; Eltan SB; Aydemir S; Akidagi Z; Bentli E; Nain E; Kasap N; Baser D; Altintas DU; Camcioglu Y; Yesil G; Ozen A; Koker MY; Karakoc-Aydiner E; Baris S
    J Allergy Clin Immunol Pract; 2020; 8(10):3525-3534.e1. PubMed ID: 32736065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome.
    Falcone EL; Abusleme L; Swamydas M; Lionakis MS; Ding L; Hsu AP; Zelazny AM; Moutsopoulos NM; Kuhns DB; Deming C; Quiñones M; Segre JA; Bryant CE; Holland SM
    Microbiome; 2016 Apr; 4():13. PubMed ID: 27044504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes, renal and cardiovascular disease in p47 phox-/- chronic granulomatous disease.
    Leiding JW; Marciano BE; Zerbe CS; Deravin SS; Malech HL; Holland SM
    J Clin Immunol; 2013 May; 33(4):725-30. PubMed ID: 23386289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Diagnostic Tool for p47
    Wrona D; Siler U; Reichenbach J
    Mol Ther Methods Clin Dev; 2019 Jun; 13():274-278. PubMed ID: 30859112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update).
    Roos D; van Leeuwen K; Hsu AP; Priel DL; Begtrup A; Brandon R; Rawat A; Vignesh P; Madkaikar M; Stasia MJ; Bakri FG; de Boer M; Roesler J; Köker N; Köker MY; Jakobsen M; Bustamante J; Garcia-Morato MB; Shephard JLV; Cagdas D; Tezcan I; Sherkat R; Mortaz E; Fayezi A; Shahrooei M; Wolach B; Blancas-Galicia L; Kanegane H; Kawai T; Condino-Neto A; Vihinen M; Zerbe CS; Holland SM; Malech HL; Gallin JI; Kuhns DB
    Blood Cells Mol Dis; 2021 Dec; 92():102596. PubMed ID: 34547651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different unequal cross-over events between NCF1 and its pseudogenes in autosomal p47(phox)-deficient chronic granulomatous disease.
    Hayrapetyan A; Dencher PC; van Leeuwen K; de Boer M; Roos D
    Biochim Biophys Acta; 2013 Oct; 1832(10):1662-72. PubMed ID: 23688784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
    Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
    Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.